{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:56:56Z","timestamp":1760853416575,"version":"3.37.0"},"reference-count":182,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["neurotox res"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1007\/bf03033793","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T17:44:58Z","timestamp":1248111898000},"page":"179-203","source":"Crossref","is-referenced-by-count":10,"title":["The neuroprotectant properties of glutamate antagonists and antiglutamatergic drugs"],"prefix":"10.1007","volume":"2","author":[{"given":"Vera","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner J.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03033793_CR1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0167-4781(94)00189-A","volume":"1260","author":"S.L. Adams","year":"1995","unstructured":"Adams, S.L., Foldes, R.L. and Kamboj, R.K. (1995) Human N-methyl-D-aspartate receptor modulatory subunit hNR3: cloning and sequencing of the cDNA and primary structure of the protein.Biochim. Biophys. Ada 1260, 105\u2013108.","journal-title":"Biochim. Biophys. Ada"},{"key":"BF03033793_CR2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","volume":"12","author":"R.L. Albin","year":"1989","unstructured":"Albin, R.L., Young, A.B. and Penney, J.B. (1989) The functional anatomy of basal ganglia disorders.Trends Neurosci. 12, 366\u2013375.","journal-title":"Trends Neurosci."},{"key":"BF03033793_CR3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0166-2236(98)01353-8","volume":"21","author":"T.E. Allsopp","year":"1998","unstructured":"Allsopp, T.E. (1998) Ageing brains and ebbing synapses.Trends Neurosci. 21, 503\u2013504.","journal-title":"Trends Neurosci."},{"key":"BF03033793_CR4","first-page":"289","volume":"36","author":"M Altagracia","year":"1993","unstructured":"Altagracia, M, Rojas, P., Kravzov, J. and Rios, C. (1993) Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson\u2019s disease.Proc. West. Pharmacol. Soc. 36, 289\u2013291.","journal-title":"Proc. West. Pharmacol. Soc."},{"key":"BF03033793_CR5","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1523\/JNEUROSCI.16-05-01710.1996","volume":"16","author":"A.J. Anderson","year":"1996","unstructured":"Anderson, A.J., Su, J.H. and Cotman, C.W. (1996) DNA damageandapoptosis in Alzheimer\u2019sdisease:colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay.J. Neurosci. 16, 1710\u20131719.","journal-title":"J. Neurosci."},{"key":"BF03033793_CR6","first-page":"603","volume":"12","author":"P. Anglade","year":"1997","unstructured":"Anglade, P., Vyas, S., Hirsch, E.C. and Agid, Y. (1997a) Apoptosis in dopaminergic neurons of the human substentia nigra during normal aging.Histol. Histopathol. 12, 603\u2013610.","journal-title":"Histol. Histopathol."},{"key":"BF03033793_CR7","first-page":"25","volume":"12","author":"P. Anglade","year":"1997","unstructured":"Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M.-T., Michel, P.P., Marquez, J., Mouatt-Prigent, A., Ruberg, M., Hirsch, E.C. and Agid, Y. (1997b) Apoptosis and autophagy in nigral neurons of patients with Parkinson\u2019s disease.Histol. Histopathol. 12, 25\u201331.","journal-title":"Histol. Histopathol."},{"key":"BF03033793_CR8","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0896-6273(95)90186-8","volume":"15","author":"M. Ankarcrona","year":"1995","unstructured":"Ankarcrona, M., Dypbukt, J.M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S.A. and Nicotera, P. (1995) Glutamate- induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function.Neuron 15, 961\u2013973.","journal-title":"Neuron"},{"key":"BF03033793_CR9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/PL00020002","volume":"190","author":"T. Araki","year":"1990","unstructured":"Araki, T., Kogure, K. and Nishioka, K. (1990) Comparative neuroprotective effects of pentobarbital, vinpocetine, flunarizine and ifenprodil on ischemic neuronal damage in the gerbil hippocampus. Res.Exp. Med. Berl. 190, 19\u201323.","journal-title":"Exp. Med. Berl."},{"key":"BF03033793_CR10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0006-8993(98)00698-2","volume":"805","author":"P.J.E. Attwell","year":"1999","unstructured":"Attwell, P.J.E., Kent, N.S., Jane, D.E., Croucher, M.J. and Bradford, H.E (1999) Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2\u2032R;3\u2032R)-2- (S,2\u2032R;3 \u2032;R)-2-(2\u2032,3\u2032-dicarboxycyclopropyDglycine (DCG- IV).Brain Res. 805, 138\u2013143.","journal-title":"Brain Res."},{"key":"BF03033793_CR11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0014-2999(98)00551-2","volume":"356","author":"G. Battaglia","year":"1998","unstructured":"Battaglia, G., Bruno, V, Ngomba, R.T., DiGrezia, R., Copani, A. and Nicoletti, F. (1998) Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death.Eur. J. Pharmacol. 356, 271\u2013274.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033793_CR12","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1096\/fasebj.6.15.1464368","volume":"6","author":"M.F. Beal","year":"1992","unstructured":"Beal, M.F. (1992) Mechanisms of excitotoxicity in neurologic diseases.FASEB J. 6, 3338\u20133344.","journal-title":"FASEB J."},{"key":"BF03033793_CR13","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","volume":"13","author":"M.F. Beal","year":"1993","unstructured":"Beal, M.F., Brouillet, E., Jenkins, B.G., Ferrante, J., Kowall, N.W., Miller, J.M., Storey, E., Srivastava, R., Rosen, B.R. and Hyman, B.T. (1993a) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.J. Neurosci. 13, 4181\u20134192.","journal-title":"J. Neurosci."},{"key":"BF03033793_CR14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0166-2236(93)90117-5","volume":"16","author":"M.F. Beal","year":"1993","unstructured":"Beal, M.F., Hyman, B.T. and Koroshetz, W. (1993b) Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?Trends Neurosci. 16, 125\u2013131.","journal-title":"Trends Neurosci."},{"key":"BF03033793_CR15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0014-2999(95)00362-O","volume":"284","author":"A. Benazzouz","year":"1995","unstructured":"Benazzouz, A., Boraud, T., Dubedat, P., Boireau, A., Stutzmann, J.M. and Gross, C. (1995) Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study.Eur.J. Pharmacol. 284, 299\u2013307.","journal-title":"Eur.J. Pharmacol."},{"key":"BF03033793_CR16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","volume":"330","author":"G. Bensimon","year":"1994","unstructured":"Bensimon, G., Lacomblez, L. and Meininger, V. (1994) A controlled trial of riluzole in amyotrophic lateral sclerosis: ALS\/Riluzole Study Group.N. Engl. J. Med. 330, 585\u2013591.","journal-title":"N. Engl. J. Med."},{"key":"BF03033793_CR17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/mds.870130507","volume":"13","author":"P.J. Blanchet","year":"1998","unstructured":"Blanchet, P.J., Konitsiotis, S. and Chase, T.N. (1998) Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys.Mov. Disord. 13, 798\u2013802.","journal-title":"Mov. Disord."},{"key":"BF03033793_CR18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1358\/dot.1999.35.6.544933","volume":"35","author":"F. Blandini","year":"1999","unstructured":"Blandini, F. and Greenamyre, J.T. (1999) Protective and symptomatic strategies for therapy of Parkinson\u2019s disease.Drugs Tod. 35, 473\u2013483.","journal-title":"Drugs Tod."},{"key":"BF03033793_CR19","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1097\/00001756-199412000-00056","volume":"5","author":"F. Block","year":"1994","unstructured":"Block, F., Pergande, G. and Schwarz, M. (1994) Flupirtine protects against ischaemic retinal dysfunction in rats.Neuroreport 5, 2630\u20132632.","journal-title":"Neuroreport"},{"key":"BF03033793_CR20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0006-8993(97)00096-6","volume":"754","author":"F. Block","year":"1997","unstructured":"Block, F., Pergande, G. and Schwarz, M. (1997) Flupirtine reduces functional deficits and neuronal damage after global ischemia in rats.Brain Res. 754, 279\u2013284.","journal-title":"Brain Res."},{"key":"BF03033793_CR21","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1097\/00001756-199412000-00063","volume":"5","author":"A. Boireau","year":"1994","unstructured":"Boireau, A., Dubedat, P., Bordier, F., Peny, C, Miquet, J.M., Durand, G., Meunier, M. and Doble, A. (1994a) Riluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in mice.Neuroreport 5, 2657\u20132660.","journal-title":"Neuroreport"},{"key":"BF03033793_CR22","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/00001756-199410270-00042","volume":"5","author":"A. Boireau","year":"1994","unstructured":"Boireau, A., Miquet, J.M., Dubedat, P., Meunier, M. and Doble, A. (1994b) Riluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in ratsin vivo.Neuroreport 5, 2157\u20132160.","journal-title":"Neuroreport"},{"key":"BF03033793_CR23","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/00001756-199804200-00042","volume":"9","author":"A. Bond","year":"1998","unstructured":"Bond, A., O\u2019Neill, M.J., Hicks, CA., Monn, J.A. and Lodge, D. (1998) Neuroprotective effects of a systemically active Group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia.Neuroreport 9, 1191\u20131193.","journal-title":"Neuroreport"},{"key":"BF03033793_CR24","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1073\/pnas.92.16.7162","volume":"92","author":"E. Bonfoco","year":"1995","unstructured":"Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P. and Lipton, S.A. (1995) Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide\/superoxide in cortical cell cultures.Proc. Natl. Acad. Sci. USA 92, 7162\u20137166.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF03033793_CR25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0301-0082(98)00095-1","volume":"59","author":"F. Bordi","year":"1999","unstructured":"Bordi, F. and Ugolini, A. (1999) Group I metabotropic glutamate receptors: implications for brain diseases.Prog. Neurobiol. 59, 55\u201379.","journal-title":"Prog. Neurobiol."},{"key":"BF03033793_CR26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"H. Braak","year":"1995","unstructured":"Braak, H. and Braak, E. (1995) Staging of Alzheimer\u2019s disease- related neurofibrillary changes.Neurobiol. Aging 16, 271\u2013278.","journal-title":"Neurobiol. Aging"},{"key":"BF03033793_CR27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF01276421","volume":"103","author":"H. Braak","year":"1996","unstructured":"Braak, H., Braak, E., Yilmazer, D., de Vos, R.A.I., Jansen, E.N.H. and Bohl, J. (1996) Pattern of brain destruction in Parkinson\u2019s and Alzheimer\u2019s disease.J. Neural Transm. 103, 455\u2013490.","journal-title":"J. Neural Transm."},{"key":"BF03033793_CR28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00001756-199304000-00011","volume":"4","author":"E. Brouillet","year":"1993","unstructured":"Brouillet, E. and Beal, M.F. (1993) NMDA antagonists partially protect against MPTP induced neurotoxicity in mice.Neuroreport 4, 387\u2013390.","journal-title":"Neuroreport"},{"key":"BF03033793_CR29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","volume":"59","author":"E. Brouillet","year":"1999","unstructured":"Brouillet, E., Cond\u00e9, F., Beal, M.F. and Hantraye, P. (1999) Replicating Huntington\u2019s disease phenotype in experimental animals.Prog. Neurobiol. 59, 427\u2013468.","journal-title":"Prog. Neurobiol."},{"key":"BF03033793_CR30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00019052-199512000-00014","volume":"8","author":"E. Brouillet","year":"1995","unstructured":"Brouillet, E. and Hantraye, P. (1995) Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates.Curr. Opin. Neurol. 8, 469\u2013473.","journal-title":"Curr. Opin. Neurol."},{"key":"BF03033793_CR31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","volume":"41","author":"S.E. Browne","year":"1997","unstructured":"Browne, S.E., Bowling, A.C., MacGarvey, U., Baik, M.J., Berger, S.C., Muqit, M.M., Bird, E.D. and Beal, M.F. (1997) Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia.Ann. Neurol. 41, 646\u2013653.","journal-title":"Ann. Neurol."},{"key":"BF03033793_CR32","doi-asserted-by":"crossref","first-page":"9594","DOI":"10.1523\/JNEUROSCI.18-23-09594.1998","volume":"18","author":"V. Bruno","year":"1998","unstructured":"Bruno, V., Battaglia, G., Casabona, G., Copani, A., Caciagli, F. and Nicoletti, F. (1998a) Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-\u00df.J. Neurosci. 18, 9594\u20139600.","journal-title":"J. Neurosci."},{"key":"BF03033793_CR33","first-page":"209","volume":"116","author":"V. Bruno","year":"1998","unstructured":"Bruno, V., Battaglia, G., Copani, A., Casabona, G., Storto, M., Gerevini, V.D., Ngomba, R. and Nicoletti, F. (1998b) Metabotropic glutamate receptors and neurodegeneration.Glutamate Synapse as a Therapeutical Target Molecular Organization and Pathology of the Glutamate Synapse 116, 209\u2013221.","journal-title":"Glutamate Synapse as a Therapeutical Target Molecular Organization and Pathology of the Glutamate Synapse"},{"key":"BF03033793_CR34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0028-3908(98)00159-2","volume":"38","author":"V Bruno","year":"1999","unstructured":"Bruno, V, Battaglia, G., Kingston, A., O\u2019Neill, M.J., Catania, M.V., Di Grezia, R. and Nicoletti, F. (1999) Neuroprotective activity of the potent and selective mGlula metabotropic glutamate receptor antagonist, (+)-2- methyl-4 caroxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlula and mGlu5 receptors.Neuropharmacology 38, 199\u2013207.","journal-title":"Neuropharmacology"},{"key":"BF03033793_CR35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0306-4522(98)00129-8","volume":"87","author":"N.J. Butterworth","year":"1998","unstructured":"Butterworth, N.J., Williams, L., Bullock, J.Y., Love, D.R., Faull, R.L. and Dragunow, M. (1998) Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington\u2019s disease striatum.Neuroscience 87, 49\u201353.","journal-title":"Neuroscience"},{"key":"BF03033793_CR36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02246054","volume":"119","author":"C.B. Carroll","year":"1995","unstructured":"Carroll, C.B., Holloway, V, Brotchie, J.M. and Mitchell, I.J. (1995) Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: functional implications for treatment of parkinsonian symptoms.Psychopharmacology Berl. 119, 55\u201365.","journal-title":"Psychopharmacology Berl."},{"key":"BF03033793_CR37","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0022-3565(25)13282-5","volume":"247","author":"C Carter","year":"1988","unstructured":"Carter, C, Benavides, J., Legendre, P., Vincent, J.D., Noel, F., Thuret, E, Lloyd, K.G., Arbilla, S., Zivkovic, B. and MacKenzie, E.T. (1988) Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D- aspartate receptor antagonist properties.J. Pharmacol. Exp. Therap. 247, 1222\u20131232.","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"BF03033793_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(98)00046-0","volume":"19","author":"D.S. Cassarino","year":"1999","unstructured":"Cassarino, D.S. and Bennett Jr., J.P. (1999) An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration.Brain Res. Rev. 19, 1\u201325.","journal-title":"Brain Res. Rev."},{"key":"BF03033793_CR39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0304-3940(93)90531-O","volume":"150","author":"M.A. Castro-Alamancos","year":"1993","unstructured":"Castro-Alamancos, M.A. and Borrell, J. (1993) Motor activity induced by disinhibition of the primary motor cortex of the rat is blocked by a non-NMDA glutamate receptor antagonist.Neurosci. Lett. 150, 183\u2013186.","journal-title":"Neurosci. Lett."},{"key":"BF03033793_CR40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0006-8993(97)01123-2","volume":"779","author":"G. Cebers","year":"1998","unstructured":"Cebers, G., Cebere, A. and Liljequist, S. (1998) Metabolic inhibition potentiates AMPA-induced Ca2+ fluxes and neurotoxicity in rat cerebellar granule cells.Brain Res. 779, 194\u2013204.","journal-title":"Brain Res."},{"key":"BF03033793_CR41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0361-9230(97)00025-7","volume":"43","author":"G. Cebers","year":"1997","unstructured":"Cebers, G., Zhivotovsky, B., Ankarcrona, M. and Liljequist, S. (1997) AMPA neurotoxicity in cultured cerebellar granule neurons: mode of cell death.Brain Res. Bull. 43, 393\u2013403.","journal-title":"Brain Res. Bull."},{"key":"BF03033793_CR42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0022-3565(24)36409-2","volume":"280","author":"P. Chan","year":"1997","unstructured":"Chan, P., Di Monte, D.A., Langsten, J.W. and Janson, A.M. (1997) (+)MK-801 does not prevent MPTP-induced loss of nigral neurons in mice.J. Pharmacol. Exp. Therap. 280, 439\u2013446.","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"BF03033793_CR43","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1523\/JNEUROSCI.12-11-04427.1992","volume":"12","author":"H.S. Chen","year":"1992","unstructured":"Chen, H.S., Pellegrini, J.W., Aggarwal, S.K., Lei, S.Z., Warach, S., Jensen, F.E. and Lipton, S.A. (1992) Open- channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity.J. Neurosci. 12, 4427\u20134436.","journal-title":"J. Neurosci."},{"key":"BF03033793_CR44","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2174\/138161280504230110102541","volume":"5","author":"B.L. Chenard","year":"1999","unstructured":"Chenard, B.L. and Menniti, F.S. (1999) Antagonists selective for NMDA receptors containing the NR2B subunit.Curr. Pharmac. Des. 5, 381\u2013404.","journal-title":"Curr. Pharmac. Des."},{"key":"BF03033793_CR45","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1523\/JNEUROSCI.07-02-00369.1987","volume":"7","author":"D.W. Choi","year":"1987","unstructured":"Choi, D.W. (1987) Ionic dependence of glutamate neurotoxicity.J. Neurosci. 7, 369\u2013379.","journal-title":"J. Neurosci."},{"key":"BF03033793_CR46","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0166-2236(88)90200-7","volume":"11","author":"D.W. Choi","year":"1988","unstructured":"Choi, D.W. (1988) Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischmic damage.Trends Neurosci. 11, 465\u2013469.","journal-title":"Trends Neurosci."},{"key":"BF03033793_CR47","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0166-2236(87)90175-5","volume":"10","author":"G.L. Collingridge","year":"1987","unstructured":"Collingridge, G.L. and Bliss, T.V.P. (1987) NMDA receptors \u2014 their role in long-term potentiation.Trends Neurosci. 10, 288\u2013293.","journal-title":"Trends Neurosci."},{"key":"BF03033793_CR48","first-page":"143","volume":"41","author":"G.L. Collingridge","year":"1989","unstructured":"Collingridge, G.L. and Lester, R.A. (1989) Excitatory amino acid receptors in the vertebrate central nervous system.Pharmacol. Rev. 41, 143\u2013210.","journal-title":"Pharmacol. Rev."},{"key":"BF03033793_CR49","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0165-6147(90)90011-V","volume":"11","author":"G.L. Collingridge","year":"1990","unstructured":"Collingridge, G.L. and Singer, W. (1990) Excitatory amino acid receptors and synaptic plasticity.Trends Pharmacol. Set. 11, 290\u2013296.","journal-title":"Trends Pharmacol. Set."},{"key":"BF03033793_CR50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0166-2236(87)90172-X","volume":"10","author":"C.W. Cotman","year":"1987","unstructured":"Cotman, C.W., Monaghan, D.T., Ottersen, O.P. and Storm-Mathisen, J. (1987) Anatomical organization of excitatory amino acid receptors and their pathways.Trends Neurosci. 10, 273\u2013280.","journal-title":"Trends Neurosci."},{"key":"BF03033793_CR51","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","volume":"262","author":"J.T. Coyle","year":"1993","unstructured":"Coyle, J.T. and Puttfarcken, P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders.Science 262, 689\u2013695.","journal-title":"Science"},{"key":"BF03033793_CR52","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/0028-3908(89)90221-9","volume":"28","author":"A.R. Crossman","year":"1989","unstructured":"Crossman, A.R., Peggs, D., Boyce, S., Luquin, M.R. and Sambrook, M.A. (1989) Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey.Neuropharmacology 28, 1271\u20131273.","journal-title":"Neuropharmacology"},{"key":"BF03033793_CR53","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/183611a0","volume":"183","author":"D.R. Curtis","year":"1959","unstructured":"Curtis, D.R., Phillis, J.W. and Watkins, J.C. (1959) Chemical excitation of spinal neurons.Nature 183, 611\u2013612.","journal-title":"Nature"},{"key":"BF03033793_CR54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1471-4159.1960.tb13458.x","volume":"6","author":"D.R. Curtis","year":"1960","unstructured":"Curtis, D.R. and Watkins, J.C. (1960) The excitation and depression of spinal neurons by structurally related amino acids.J. Neurochem. 6, 117\u2013141.","journal-title":"J. Neurochem."},{"key":"BF03033793_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.1963.sp007087","volume":"66","author":"D.R. Curtis","year":"1963","unstructured":"Curtis, D.R. and Watkins, J.C. (1963) Acidic amino acids with strong excitatory actions on mammalian neurons.J. Physiol. 66, 1\u201314.","journal-title":"J. Physiol."},{"key":"BF03033793_CR56","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/brain\/122.8.1421","volume":"122","author":"P. Damier","year":"1999","unstructured":"Damier, P., Hirsch, E.C., Agid, Y. and Graybiel, A.M. (1999a) The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D28K immunohistochemistry.Brain 122,1421\u20131436.","journal-title":"Brain"},{"key":"BF03033793_CR57","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","volume":"122","author":"P. Damier","year":"1999","unstructured":"Damier, P., Hirsch, E.C., Agid, Y. and Graybiel, A.M. (1999b) The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease.Brain 122, 1437\u20131448.","journal-title":"Brain"},{"key":"BF03033793_CR58","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0149-7634(96)00037-1","volume":"21","author":"W. Danysz","year":"1997","unstructured":"Danysz, W., Parsons, CG., Kornhuber, J. and Schmidt, W.J. (1997) Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents \u2014 preclinical studies.Neurosci. Biobehav. Rev. 21, 455\u2013468.","journal-title":"Neurosci. Biobehav. Rev."},{"key":"BF03033793_CR59","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/30748","volume":"393","author":"S. Das","year":"1998","unstructured":"Das, S., Sasaki, Y.E, Rothe, T., Premkumar, L.S., Takasu, M., Crandall, J.E., Dikkes, P., Conner, D.A., Rayudu, P.V., Cheung, W., Chen, H.S., Lipton, S.A. and Nakanishi, N. (1998) Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A.Nature 393, 377\u2013381.","journal-title":"Nature"},{"key":"BF03033793_CR60","first-page":"401","volume":"78","author":"S.M. Monte de la","year":"1998","unstructured":"de la Monte, S.M., Sohn, Y.K., Ganju, N. and Wands, J.R. (1998) P53- and CD95-associated apoptosis in neurodegenerative diseases.Lab. Invest. 78, 401\u2013411.","journal-title":"Lab. Invest."},{"key":"BF03033793_CR61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","volume":"52","author":"D.T. Dexter","year":"1989","unstructured":"Dexter, D.T., Carter, C.J., Wells, ER., Javoy-Agid, F., Agid, Y, Lees, A., Jenner, P. and Marsden, CD. (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson\u2019s disease.J. Neurochem. 52, 381\u2013389.","journal-title":"J. Neurochem."},{"key":"BF03033793_CR62","first-page":"961","volume":"14","author":"R. Diamond","year":"1992","unstructured":"Diamond, R., White, R.F., Myers, R.H., Mastromauro, C., Koroshetz, W.J., Butters, N., Rothstein, D.M., Moss, M.B. and Vasterling, J. (1992) Evidence of presymptomatic cognitive decline in Huntington\u2019s disease.J. Clin. Exp. Neurol. 14, 961\u2013975.","journal-title":"J. Clin. Exp. Neurol."},{"key":"BF03033793_CR63","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0163-7258(98)00042-4","volume":"81","author":"A. Doble","year":"1999","unstructured":"Doble, A. (1999) The role of excitotoxicity in neurodegenerative disease: implications for therapy.Pharmacol. Ther. 81, 163\u2013221.","journal-title":"Pharmacol. Ther."},{"key":"BF03033793_CR64","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00001756-199505090-00026","volume":"6","author":"M. Dragunow","year":"1995","unstructured":"Dragunow, M., Faull, R.L., Lawlor, P., Beilharz, E.J., Singleton, K., Walker, E.B. and Mee, E. (1995)In situ evidence for DNA fragmentation in Huntington\u2019s disease striatum and Alzheimer\u2019s disease temporal lobes.Neuroreport 6, 1053\u20131057.","journal-title":"Neuroreport"},{"key":"BF03033793_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0173(95)00003-L","volume":"21","author":"M. Dragunow","year":"1995","unstructured":"Dragunow, M. and Preston, K. (1995) The role of inducible transcription factors in apoptotic nerve cell death.Brain Res. Rev. 21, 1\u201328.","journal-title":"Brain Res. Rev."},{"key":"BF03033793_CR66","doi-asserted-by":"crossref","first-page":"A33","DOI":"10.1038\/399a032","volume":"399","author":"S.B. Dunnett","year":"1999","unstructured":"Dunnett, S.B. and Bj\u00f6rklund, A. (1999) Prospects for new restorative and neuroprotective treatments in Parkinson\u2019s disease.Nature 399 (Suppl.), A33-A39.","journal-title":"Nature"},{"key":"BF03033793_CR67","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1073\/pnas.87.5.1983","volume":"87","author":"M. Favaron","year":"1990","unstructured":"Favaron, M., Manev, H., Siman, R., Bertolino, M., Szekely, A.M., DeErausquin, G., Guidotti, A. and Costa, E. (1990) Down-regulation of protein kinase C protects cerebellar gra nule neurons in primary culture from glutamate-induced neuronal death.Proc. Natl. Acad. Sci. USA 87, 1983\u20131987.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF03033793_CR68","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1046\/j.1471-4159.1997.69052064.x","volume":"69","author":"R.J. Ferrante","year":"1997","unstructured":"Ferrante, R.J., Browne, S.E., Shinobu, L.A., Bowling, A.C., Baik, M.J., MacGarvey, U., Kowall, N.W, Brown-RH, J. and Beal, M.F. (1997) Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis.J. Neurochem. 69, 2064\u20132074.","journal-title":"J. Neurochem."},{"key":"BF03033793_CR69","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/exnr.1993.1153","volume":"123","author":"A.S. Fix","year":"1993","unstructured":"Fix, A.S., Horn, J.W., Wightman, K.A., Johnson, CA., Long, G.G., Starts, R.W., Farber, N., Wozniak, D.F. and Olney, J.W. (1993) Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartat (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex.Exp. Neurol. 123, 204\u2013215.","journal-title":"Exp. Neurol."},{"key":"BF03033793_CR70","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2165\/00003495-199345040-00007","volume":"45","author":"H.A. Friedel","year":"1993","unstructured":"Friedel, H.A. and Fitton, A. (1993) Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states.Drugs 45, 548\u2013569.","journal-title":"Drugs"},{"key":"BF03033793_CR71","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/S0022-3565(24)38321-1","volume":"289","author":"E Gasparini","year":"1999","unstructured":"Gasparini, E, Bruno, V., Battaglia, G., Lukic, S., Leonhardt, T., Inderbitzin, W., Laurie, D., Sommer, B., Varney, M.A., Hess, S.D., Johnson, E.C., Kuhn, R., Urwyler, S., Sauer, D., Portet, C, Schmutz, M., Nicoletti, F. and Flor, P.J. (1999) (R,S)-4-phosphonophenylglycine, a potent and selective groupIII metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotectivein vivo.J. Pharmacol. Exp. Therap. 289, 1678\u20131687.","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"BF03033793_CR72","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0301-0082(95)80004-R","volume":"47","author":"P. Gass","year":"1995","unstructured":"Gass, P. and Herdegen, T. (1995) Neuronal expression of AP-1 proteins in excitotoxic-neurodegenerative disorders and following nerve fiber lesion.Prog. Neurobiol. 47, 257\u2013290.","journal-title":"Prog. Neurobiol."},{"key":"BF03033793_CR73","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0092-8674(00)80748-5","volume":"97","author":"FG. Gervais","year":"1999","unstructured":"Gervais, FG., Xu, D.G., Robertson, G.S., Vaillancourt, J.P., Zhu, Y.X., Huang, J.Q., LeBlanc, A., Smith, D., Rigby, M., Shearman, M.S., Clarke, F.E., Zheng, H., Van-Der-Ploeg, L.H.T., Ruffolo, S.C., Thornberry, N.A., Xanthoudakis, S., Zamboni, R.J., Roy, S. and Nicholson, D.W. (1999) Involve- ment of caspases in proteolytic cleavage of Alzheimer\u2019s amyloid-beta precursor protein and amyloidogenic A beta peptide formation.Cell 97, 395\u2013406.","journal-title":"Cell"},{"key":"BF03033793_CR74","first-page":"904","volume":"42","author":"R. Gortelmeyer","year":"1992","unstructured":"Gortelmeyer, R. and Erbler, H. (1992) Memantine in the treatment of mild to moderate dementia syndrome. A doubleblind placebo-controlled study.Arzneimittelforschung. 42, 904\u2013913.","journal-title":"Arzneimittelforschung."},{"key":"BF03033793_CR75","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0022-3565(25)13281-3","volume":"247","author":"B. Gotti","year":"1988","unstructured":"Gotti, B., Duverger, D., Bertin, J., Carter, C, Dupont, R., Frost, J., Gaudilliere, B., MacKenzie, E.T., Rousseau, J. and Scatton, B. (1988) Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.J. Pharmacol. Exp. Therap. 247, 1211\u20131221.","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"BF03033793_CR76","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2990.1982.tb00306.x","volume":"8","author":"D.H. Gould","year":"1982","unstructured":"Gould, D.H. and Gustine, D.L. (1982) Basal ganglia degeneration, myelin alterations, and enzyme inhibition induced in mice by the plant toxin 3-nitropropionic acid.Neuropathol. Appl. Neurobiol. 8, 377\u2013393.","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BF03033793_CR77","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1046\/j.1471-4159.1995.64010430.x","volume":"64","author":"J.G. Greene","year":"1995","unstructured":"Greene, J.G. and Greenamyre, J.T. (1995a) Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate.J. Neurochem. 64, 430\u2013436.","journal-title":"J. Neurochem."},{"key":"BF03033793_CR78","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1046\/j.1471-4159.1995.64052332.x","volume":"64","author":"J.G. Greene","year":"1995","unstructured":"Greene, J.G. and Greenamyre, J.T. (1995b) Exacerbation of NMDA, AMPA and L-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate.J. Neurochem. 64, 2332\u20132338.","journal-title":"J. Neurochem."},{"key":"BF03033793_CR79","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"M. Gu","year":"1996","unstructured":"Gu, M., Gash, M.T., Mann, V.M., Javoy, A.F., Cooper, J.M. and Schapira, A.H. (1996) Mitochondrial defect in Huntington\u2019s disease caudate nucleus.Ann. Neurol. 39, 385\u2013389.","journal-title":"Ann. Neurol."},{"key":"BF03033793_CR80","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0306-4522(97)00192-9","volume":"81","author":"M.C. Guyot","year":"1997","unstructured":"Guyot, M.C., Palfi, S., Stutzmann, J.M., Maziere, M., Hantraye, P. and Brouillet, E. (1997) Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats.Neuroscience 81, 141\u2013149.","journal-title":"Neuroscience"},{"key":"BF03033793_CR81","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0022-3565(24)37253-2","volume":"284","author":"D.R. Helton","year":"1998","unstructured":"Helton, D.R., Tizzano, J.P., Monn, J.A., Schoepp, D.D. and Kallman, M.J. (1998) Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors.J. Pharmacol. Exp.Themp. 284, 651\u2013660.","journal-title":"J. Pharmacol. Exp.Themp."},{"key":"BF03033793_CR82","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1749-6632.1989.tb12512.x","volume":"568","author":"R.C. Henneberry","year":"1989","unstructured":"Henneberry, R.C., Novelli, A., Cox, J.A. and Lysko, P.G. (1989a) Neurotoxicity at the N-methyl-D-aspartate receptor in energy-compromised neurons. A hypothesis for cell death in aging and disease.Ann. NY Acad. Sci. 568, 225\u2013233.","journal-title":"Ann. NY Acad. Sci."},{"key":"BF03033793_CR83","first-page":"143","volume":"317","author":"R.C. Henneberry","year":"1989","unstructured":"Henneberry, R.C., Novelli, A., Vigano, M.A., Reilly, J.A., Cox, J.A. and Lysko, P.G. (1989b) Energy-related neurotoxicity at the NMDA receptor: a possible role in Alzheimer\u2019s disease and related disorders.Prog. Clin. Biol. Res. 317, 143\u2013156.","journal-title":"Prog. Clin. Biol. Res."},{"key":"BF03033793_CR84","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/00001756-199804200-00006","volume":"9","author":"P. Henrich-Noack","year":"1998","unstructured":"Henrich-Noack, P., Hatton, CD. and Reymann, K.G. (1998) The mGlu receptor ligand (S)-4C3HPG protects neurons after global ischaemia in gerbils.Neuroreport 9, 985\u2013988.","journal-title":"Neuroreport"},{"key":"BF03033793_CR85","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0165-0173(98)00018-6","volume":"28","author":"T. Herdegen","year":"1998","unstructured":"Herdegen, T. and Leah, J.D. (1998) Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB\/ ATF proteins.Brain Res. Rev. 28, 370\u2013490.","journal-title":"Brain Res. Rev."},{"key":"BF03033793_CR86","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1073\/pnas.84.16.5976","volume":"84","author":"E.C. Hirsch","year":"1987","unstructured":"Hirsch, E.C., Graybiel, A.M., Duyckaerts, C. and Javoy-Agid, F. (1987) Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy.Proc. Natl. Acad. Sci. USA 84, 5976\u20135980.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF03033793_CR87","first-page":"83","volume":"1","author":"E.C. Hirsch","year":"1992","unstructured":"Hirsch, E.C., Mouatt, A., Thomasset, M., Javoy-Agid, F., Agid, Y. and Graybiel, A.M. (1992) Expression of Calbindin D28K-like immunoreactivity in catecholaminergic cell groups of the human midbrain: normal distribution and distribution in Parkinson\u2019s disease.Neurodegeneration 1, 83\u201393.","journal-title":"Neurodegeneration"},{"key":"BF03033793_CR88","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/hmg\/2.12.2069","volume":"2","author":"A.T. Hoogeveen","year":"1993","unstructured":"Hoogeveen, A.T., Willemsen, R., Meyer, N., de Rooij, K.E., Roos, R.A., van-Ommen, G.J. and Galjaard, H. (1993) Characterization and localization of the Huntington disease gene product.Hum. Mol. Genet. 2, 2069\u20132073.","journal-title":"Hum. Mol. Genet."},{"key":"BF03033793_CR89","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0149-7634(98)00045-1","volume":"23","author":"C H\u00f6lscher","year":"1999","unstructured":"H\u00f6lscher, C, Gigg, J. and O\u2019Mara, S.M. (1999) Metabotropic glutamate receptor activation and blockade: their role in long-term potentiation, learning and neurotoxicity.Neurosci. Biobehav. Rev. 23, 399\u2013410.","journal-title":"Neurosci. Biobehav. Rev."},{"key":"BF03033793_CR90","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0166-2236(96)10074-6","volume":"20","author":"C. Iadecola","year":"1997","unstructured":"Iadecola, C. (1997) Bright and dark sides of nitric oxide in isch\u00e9mie brain injury.Trends Neurosci. 20, 132\u2013139.","journal-title":"Trends Neurosci."},{"key":"BF03033793_CR91","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.283.5398.70","volume":"283","author":"C Ikonomidou","year":"1999","unstructured":"Ikonomidou, C, Bosch, F., Miksa, M., Bittigau, P., Vockler, J., Dikranian, K., Tenkova, T.I., Stefovska, V., Turski, L. and Olney, J.W. (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain.Science 283, 70\u201374.","journal-title":"Science"},{"key":"BF03033793_CR92","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/(SICI)1096-9861(19990614)408:4<461::AID-CNE2>3.0.CO;2-9","volume":"408","author":"M.J. Ishimaru","year":"1999","unstructured":"Ishimaru, M.J., Ikonomidou, C, Tenkova, T.I., Der, T.C., Dikranian, K., Sesma, M.A. and Olney, J.W. (1999) Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain.J. Comp. Neurol. 408, 461\u2013476.","journal-title":"J. Comp. Neurol."},{"key":"BF03033793_CR93","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03159935","volume":"14","author":"K.A. Jellinger","year":"1991","unstructured":"Jellinger, K.A. (1991) Pathology of Parkinson\u2019s disease. Changes other than the nigrostriatal pathway.Mol. Chem. Neuropathol. 14, 153\u2013197.","journal-title":"Mol. Chem. Neuropathol."},{"key":"BF03033793_CR94","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1212\/WNL.47.6_Suppl_3.161S","volume":"47","author":"P. Jenner","year":"1996","unstructured":"Jenner, P. and Olanow, C.W. (1996) Oxidative stress and the pathogenesis of Parkinson\u2019s disease.Neurology 47 (Suppl.), S161-S170.","journal-title":"Neurology"},{"key":"BF03033793_CR95","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0024-3205(94)00813-2","volume":"54","author":"S.A. Jones-Humble","year":"1994","unstructured":"Jones-Humble, S.A., Morgan, P.F. and Cooper, B.R. (1994) The novel anticonvulsant lamotrigine prevents dopamine depletion in C57 black mice in the MPTP animal model of Parkinson\u2019s disease.Life Sci. 54, 245\u2013252.","journal-title":"Life Sci."},{"key":"BF03033793_CR96","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1469-7793.1998.017bf.x","volume":"512","author":"J.N. Kew","year":"1998","unstructured":"Kew, J.N. and Kemp, J.A. (1998) An allosteric interaction between the NMDA receptor polyamine and ifenprodil sites in rat cultured cortical neurones.J. Physiol. (Lond.)512, 17\u201328.","journal-title":"J. Physiol. (Lond.)"},{"key":"BF03033793_CR97","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mds.870110310","volume":"11","author":"K. Kieburtz","year":"1996","unstructured":"Kieburtz, K., Feigin, A., McDermott, M., Como, P., Abwender, D., Zimmerman, C, Hickey, C, Orme, C, Claude, K., Sotack, J., Greenamyre, J.T., Dunn, C. and Shoulson, I. (1996) A controlled trial of remacemide hydrochloride in Huntington\u2019s disease.Mov. Disord. 11, 273\u2013277.","journal-title":"Mov. Disord."},{"key":"BF03033793_CR98","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0896-6273(94)90272-0","volume":"12","author":"L. Kiedrowski","year":"1994","unstructured":"Kiedrowski, L., Brooker, G., Costa, E. and Wroblewski, J.T. (1994) Glutamate impairs neuronal calcium extrusion while reducing sodium gradient.Neuron 12, 295\u2013300.","journal-title":"Neuron"},{"key":"BF03033793_CR99","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/mds.870130604","volume":"13","author":"A.E. Kingsbury","year":"1999","unstructured":"Kingsbury, A.E., Marsden, C.A. and Foster, O.J.F. (1999) DNA fragmentation in human substantia nigra: apoptosis or perimortem effect?Mov. Disord. 13, 877\u2013884.","journal-title":"Mov. Disord."},{"key":"BF03033793_CR100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0014-2999(99)00397-0","volume":"377","author":"A.E. Kingston","year":"1999","unstructured":"Kingston, A.E., O\u2019Neill, M.J., Lam, A., Bales, K.R., Monn, J.A. and Schoepp, D.D. (1999) Neuroprotection by metabotropic glutamate receptor agonists: LY354740, LY379268 and LY389795.Eur. J. Pharmacol. 377, 155\u2013165.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033793_CR101","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ana.410280411","volume":"28","author":"T. Klockgether","year":"1990","unstructured":"Klockgether, T. and Turski, L. (1990) NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats.Ann. Neurol. 28, 539\u2013546.","journal-title":"Ann. Neurol."},{"key":"BF03033793_CR102","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1523\/JNEUROSCI.14-05-02585.1994","volume":"14","author":"R.A. Koch","year":"1994","unstructured":"Koch, R.A. and Barish, M.E. (1994) Perturbation of intracellular calcium and hydrogen ion regulation in cultured mouse hippocampal neurons by reduction of the sodium ion concentration gradient.J. Neurosci. 14, 2585\u20132593.","journal-title":"J. Neurosci."},{"key":"BF03033793_CR103","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/PL00005284","volume":"358","author":"J. Konieczny","year":"1998","unstructured":"Konieczny, J., Ossowka, K., Wolfarth, S. and Pilc, A. (1998) LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats.Naunyn Schmiedeberg\u2019s Arch. Pharmacol. 358, 500\u2013502.","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"BF03033793_CR104","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s004010051054","volume":"98","author":"J. Kornhuber","year":"1999","unstructured":"Kornhuber, J., Jellinger, K.A., Wiltfang, J., Leblhuber, F. and Riederer, P. (1999) The N-methyl-D-aspartate receptor channel blocker amantadine does not cause histo- pathological alterations in human brain tissue.Acta Neuropathol. 98, 85\u201390.","journal-title":"Acta Neuropathol."},{"key":"BF03033793_CR105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0304-3940(94)90948-2","volume":"179","author":"B.D. Kretschmer","year":"1994","unstructured":"Kretschmer, B.D. (1994a) Felbamate, an anti-convulsive drug, has anti-parkinsonian potential in rats.Neurosci. Lett. 179, 115\u2013118.","journal-title":"Neurosci. Lett."},{"key":"BF03033793_CR106","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF01276431","volume":"95","author":"B.D. Kretschmer","year":"1994","unstructured":"Kretschmer, B.D., Winterscheid, B., Danysz, W. and Schmidt, W.J. (1994b) Glycine site antagonists abolish dopamine D2 but not Dl receptor mediated catalepsy in rats.J. Neural Transm. Gen. Sect. 95, 123\u2013136.","journal-title":"J. Neural Transm. Gen. Sect."},{"key":"BF03033793_CR107","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(98)00593-X","volume":"253","author":"U. Kronthaler","year":"1998","unstructured":"Kronthaler, U. and Schmidt, W.J. (1998) The mGluRs group II agonist (2S,3S,4S)-alpha-carboxycyclopropyl-glycine induces catalepsy in the rat, which is pronouncedly antagonised by dizocilpine and D,L-amphetamine.Neurosci. Lett. 253, 25\u201328.","journal-title":"Neurosci. Lett."},{"key":"BF03033793_CR108","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0006-8993(92)91660-7","volume":"592","author":"A. Kupsch","year":"1992","unstructured":"Kupsch, A., L\u00f6schmann, P.-A., Sauer, H., Arnold, G., Renner, P., Pufal, D., Burg, M., Wachtel, H., ten-Bruggencate, G. and Oertel, W.H. (1992) Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice.Brain Res. 592, 74\u201383.","journal-title":"Brain Res."},{"key":"BF03033793_CR109","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","volume":"347","author":"L. Lacomblez","year":"1996","unstructured":"Lacomblez, L., Bensimon, G., Leigh, P.N., Guillet, P. and Meininger, V. (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis\/Riluzole Study Group II.Lancet 347, 1425\u20131431.","journal-title":"Lancet"},{"key":"BF03033793_CR110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3940(98)00651-X","volume":"254","author":"A.G.M. Lam","year":"1998","unstructured":"Lam, A.G.M., Soriano, M.A., Monn, J.A., Schoepp, D.D., Lodge, D. and McCulloch, J. (1998) Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischemia.Neurosci. Lett. 254, 121\u2013123.","journal-title":"Neurosci. Lett."},{"key":"BF03033793_CR111","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0149-7634(96)00043-7","volume":"21","author":"K.W Lange","year":"1997","unstructured":"Lange, K.W, Kornhuber, J. and Riederer, P. (1997) Dopamine\/ glutamate interactions in Parkinson\u2019s disease.Neurosci. Biobehav. Rev. 21, 393\u2013400.","journal-title":"Neurosci. Biobehav. Rev."},{"key":"BF03033793_CR112","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/BF00167234","volume":"348","author":"K.W. Lange","year":"1993","unstructured":"Lange, K.W., L\u00f6schmann, P.-A., Sofie, E., Burg, M., Horowski, R., Kalveram, K.T., Wachtel, H. and Riederer, P. (1993) The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates.Naunyn Schmiedebergs Arch. Pharmacol. 348, 586\u2013592.","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"BF03033793_CR113","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1038\/399a007","volume":"399","author":"J.-M. Lee","year":"1999","unstructured":"Lee, J.-M., Zipfel, G.J. and Choi, D.W. (1999) The changing landscape of ischaemic brain injury mechanisms.Nature 399 (Suppl.), A7-A14.","journal-title":"Nature"},{"key":"BF03033793_CR114","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0026-895X(25)12936-2","volume":"40","author":"P. Legendre","year":"1991","unstructured":"Legendre, P. and Westbrook, G.L. (1991) Ifenprodil blocks N-methyl-D-aspartate receptors by a two-component mechanism.Mol. Pharmacol. 40, 289\u2013298.","journal-title":"Mol. Pharmacol."},{"key":"BF03033793_CR115","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1124\/mol.54.5.789","volume":"54","author":"M. Leist","year":"1998","unstructured":"Leist, M., Volbracht, C, Fava, E. and Nicotera, P. (1998) l-Methyl-4-phenylpyridinium induces autocrine excitotoxicity, protease activation, and neuronal apoptosis.Mol. Pharmacol. 54, 789\u2013801.","journal-title":"Mol. Pharmacol."},{"key":"BF03033793_CR116","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0143-4160(98)90115-4","volume":"23","author":"S.A. Lipton","year":"1998","unstructured":"Lipton, S.A. and Nicotera, P. (1998) Calcium, free radicals and excitotoxins in neuronal apoptosis.Cell Calcium 23, 165\u2013171.","journal-title":"Cell Calcium"},{"key":"BF03033793_CR117","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archopht.1957.00940010205006","volume":"58","author":"D.R. Lucas","year":"1957","unstructured":"Lucas, D.R. and Newhouse, J.P. (1957) The toxic activity of sodium-L-glutamate on the inner layers of the retina.Arch. Ophthalmol. 58, 193\u2013201.","journal-title":"Arch. Ophthalmol."},{"key":"BF03033793_CR118","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00005072-199708000-00007","volume":"56","author":"P.J. Lucassen","year":"1997","unstructured":"Lucassen, P.J., Chung, W.C.J., Kamphorts, W. and Swaab, D.F. (1997) DNA damage distribution in the human brain as shown byin situ end labeling: area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology.J. Neuropathol. Exp. Neurol. 56, 887\u2013900.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF03033793_CR119","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0404.1992.tb04003.x","volume":"85","author":"A.C. Ludolph","year":"1992","unstructured":"Ludolph, A.C., Langen, K.J., Regard, M., Herzog, H., Kemper, B., Kuwert, T., Bottger, I.G. and Feinendegen, L. (1992a) Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study.Acta Neurol. Scand. 85, 81\u201389.","journal-title":"Acta Neurol. Scand."},{"key":"BF03033793_CR120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1749-6632.1992.tb24562.x","volume":"648","author":"A.C. Ludolph","year":"1992","unstructured":"Ludolph, A.C., Seelig, M., Ludolph, A.G., Sabri, M.I. and Spencer, P.S. (1992b) ATP deficits and neuronal degeneration induced by 3-nitropropionic acid.Ann. NY Acad. Sci. 648, 300\u2013302.","journal-title":"Ann. NY Acad. Sci."},{"key":"BF03033793_CR121","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1126\/science.285.5435.1870","volume":"285","author":"R.C. Malenka","year":"1999","unstructured":"Malenka, R.C. and Nicoll, R.A. (1999) Long-term potentiation \u2014 a decade of progress?Science 285, 1870\u20131874.","journal-title":"Science"},{"key":"BF03033793_CR122","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/brain\/115.2.333","volume":"115","author":"V.M. Mann","year":"1992","unstructured":"Mann, V.M., Cooper, J.M., Krige, D., Daniel, S.E., Schapira, A.H. and Marsden, CD. (1992) Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson\u2019s disease.Brain 115, 333\u2013342.","journal-title":"Brain"},{"key":"BF03033793_CR123","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00005072-199905000-00005","volume":"58","author":"L.J. Martin","year":"1999","unstructured":"Martin, L.J. (1999) Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism.J. Neuropathol. Exp. Neurol. 58, 459\u2013471.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF03033793_CR124","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1523\/JNEUROSCI.12-02-00376.1992","volume":"12","author":"M.P. Mattson","year":"1992","unstructured":"Mattson, M.P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I. and Rydel, R.E. (1992) Beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity.J. Neurosci. 12, 376\u2013389.","journal-title":"J. Neurosci."},{"key":"BF03033793_CR125","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1471-4159.1999.0730532.x","volume":"73","author":"M.P. Mattson","year":"1999","unstructured":"Mattson, M.P., Guo, Z.H. and Geiger, J.D. (1999) Secreted form of amyloid precursor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic GMP-mediated mechanism.J. Neurochem. 73, 532\u2013537.","journal-title":"J. Neurochem."},{"key":"BF03033793_CR126","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/exnr.1998.6863","volume":"153","author":"M.P. Mattson","year":"1998","unstructured":"Mattson, M.P., Keller, J.N. and Begley, J.G. (1998) Evidence for synaptic apoptosis.Exp. Neurol. 153, 35\u201348.","journal-title":"Exp. Neurol."},{"key":"BF03033793_CR127","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1471-4159.1993.tb03545.x","volume":"61","author":"L.D. Mercer","year":"1993","unstructured":"Mercer, L.D., Jarrott, B. and Beart, P.M. (1993) 1251-ifenprodil: synthesis and characterization of binding to a polyamine- sensitive site in cerebral cortical membranes.J. Neurochem. 61, 120\u2013126.","journal-title":"J. Neurochem."},{"key":"BF03033793_CR128","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0301-0082(97)00055-5","volume":"54","author":"E.K. Michaelis","year":"1998","unstructured":"Michaelis, E.K. (1998) Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging.Prog. Neurobiol. 54, 369\u2013415.","journal-title":"Prog. Neurobiol."},{"key":"BF03033793_CR129","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0149-7634(96)00036-X","volume":"21","author":"I.J. Mitchell","year":"1997","unstructured":"Mitchell, I.J. and Carroll, C.B. (1997) Reversal of parkinsonian symptoms in primates by antagonism of excitatory amino acid transmission: potential mechanisms of action.Neurosci. Biobehav. Rev. 21, 469\u2013475.","journal-title":"Neurosci. Biobehav. Rev."},{"key":"BF03033793_CR130","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/3661","volume":"1","author":"D.D. Mott","year":"1998","unstructured":"Mott, D.D., Doherty, J.J., Zhang, S., Washburn, M.S., Fendley, M.J., Lyuboslavsky, P., Traynelis, S.F. and Dingledine, R. (1998) Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition.Nat. Neurosci. 1, 659\u2013667.","journal-title":"Nat. Neurosci."},{"key":"BF03033793_CR131","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.cdd.4400206","volume":"4","author":"W.E.G. M\u00fcller","year":"1997","unstructured":"M\u00fcller, W.E.G., Dobmeyer, J.M., Dobmeyer, T.S., Pergande, G., Perovic, S., Leuck, J. and Rossol, R. (1997a) Flupirtine protects neuronal cells and lymphocytes against induced apoptosisin vitro: implications for treatment of AIDS patients.Cell Death Diff. 4, 51\u201358.","journal-title":"Cell Death Diff."},{"key":"BF03033793_CR132","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1046\/j.1471-4159.1997.68062371.x","volume":"68","author":"W.E.G. M\u00fcller","year":"1997","unstructured":"M\u00fcller, W.E.G., Romero, F.J., Perovic, S., Pergande, G. and Pialoglou, P. (1997b) Protection of flupirtine on \u00df -amyloid- induced apoptosis in neuronal cellsin vitro: prevention of amyloid-induced glutathione depletion.J. Neurochem. 68, 2371\u20132377.","journal-title":"J. Neurochem."},{"key":"BF03033793_CR133","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/exnr.1998.6963","volume":"155","author":"J.E. Nash","year":"1999","unstructured":"Nash, J.E., Hill, M.P. and Brotchie J.M. (1999) Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated rat.Exp. Neurol. 155, 42\u201348.","journal-title":"Exp. Neurol."},{"key":"BF03033793_CR134","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0166-2236(96)20019-0","volume":"19","author":"F. Nicoletti","year":"1996","unstructured":"Nicoletti, F., Bruno, V., Copani, A., Casabona, G. and Kn\u00f6pfel, T. (1996) Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?Trends Neurosci. 19, 267\u2013271.","journal-title":"Trends Neurosci."},{"key":"BF03033793_CR135","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0165-6147(99)01304-8","volume":"20","author":"P. Nicotera","year":"1999","unstructured":"Nicotera, P., Leist, M. and Manzo, L. (1999) Neuronal cell death: a demise with different shapes.Trends Pharmacol. Sci. 20, 46\u201351.","journal-title":"Trends Pharmacol. Sci."},{"key":"BF03033793_CR136","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(88)90765-2","volume":"451","author":"A. Novelli","year":"1988","unstructured":"Novelli, A., Reilly, J.A., Lysko, P.G. and Henneberry, R.C. (1988) Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced.Brain Res. 451, 205\u2013212.","journal-title":"Brain Res."},{"key":"BF03033793_CR137","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1126\/science.164.3880.719","volume":"164","author":"J.W. Olney","year":"1969","unstructured":"Olney, J.W. (1969) Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate.Science 164, 719\u2013721.","journal-title":"Science"},{"key":"BF03033793_CR138","first-page":"95","volume-title":"Kainic Acid as a Tool in Neurobiology","author":"J.W. Olney","year":"1978","unstructured":"Olney, J.W. (1978) Neurotoxicity of excitatory amino acids. In: McGeer, E.G., Olney, J.W. and McGeer, P.L. (Eds.),Kainic Acid as a Tool in Neurobiology (New York: Raven Press), pp. 95\u2013112."},{"key":"BF03033793_CR139","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.166.3903.386","volume":"166","author":"J.W. Olney","year":"1969","unstructured":"Olney, J.W. and Sharpe, L.G. (1969) Brain lesions in an infant rhesus monkey treated with monosodium glutamate.Science 166, 386\u2013388.","journal-title":"Science"},{"key":"BF03033793_CR140","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1001\/archneur.1997.00550220042012","volume":"54","author":"J.W. Olney","year":"1997","unstructured":"Olney, J.W., Wozniak, D.F. and Farber, N.B. (1997) Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies.Arch. Neurol. 54, 1234\u20131241.","journal-title":"Arch. Neurol."},{"key":"BF03033793_CR141","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0165-6147(89)90029-1","volume":"10","author":"S. Orrenius","year":"1989","unstructured":"Orrenius, S., McConkey, D.J., Bellomo, G. and Nicotera, P. (1989) Role of Ca2+ in toxic cell killing.Trends Pharmacol. Sci. 10, 281\u2013285.","journal-title":"Trends Pharmacol. Sci."},{"key":"BF03033793_CR142","first-page":"1390","volume":"38","author":"N.N. Osborne","year":"1997","unstructured":"Osborne, N.N., Cazevieille, C, Pergande, G. and Wood, J.P.M. (1997) Induction of apoptosis in cultured human retinal pigment epithelial cells is counteracted by flupirtine.Invest. Ophthalmol. Vis. Sci. 38, 1390\u20131400.","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BF03033793_CR143","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0306-3623(97)00355-8","volume":"30","author":"M.S. Nash","year":"1998","unstructured":"Nash, M.S., Pergande, G., Block, F., Kosinski, C. and Schwarz, M. (1998) Flupirtine, a nonopioid centrally acting analgesic, acts as an NMDA antagonist.Gen. Pharmacol. 30, 255\u2013263.","journal-title":"Gen. Pharmacol."},{"key":"BF03033793_CR144","first-page":"274","volume":"37","author":"N.N. Osborne","year":"1996","unstructured":"Osborne, N.N., Schwarz, M. and Pergande, G. (1996) Protection of rabbit retina from ischemie injury by flupirtine.Invest. Ophthalmol. Vis. Sci. 37, 274\u2013280.","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BF03033793_CR145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/exnr.1997.6520","volume":"146","author":"S. Palfi","year":"1997","unstructured":"Palfi, S., Riche, D., Brouillet, E., Guyot, M.C., Mary, V, Wahl, F., Peschanski, M., Stutzmann, J.M. and Hantraye, P. (1997) Riluzole reduces incidence of abnormal movements but not striatal cell death in a primate model of progressive striatal degeneration.Exp. Neurol. 146, 135\u2013141.","journal-title":"Exp. Neurol."},{"key":"BF03033793_CR146","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1358\/dnp.1998.11.9.863689","volume":"11","author":"CG. Parsons","year":"1998","unstructured":"Parsons, CG., Danysz, W. and Quack, G. (1998) Glutamate in CNS disorders as a target for drug development: an update.Drug News Perspect. 11, 523\u2013569.","journal-title":"Drug News Perspect."},{"key":"BF03033793_CR147","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/0028-3908(93)90029-3","volume":"32","author":"CG. Parsons","year":"1993","unstructured":"Parsons, CG., Gruner, R., Rozental, J, Millar, J. and Lodge, D. (1993) Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (l-amino-3,5-dimethyladamantan).Neuropharmacology 32, 1337\u20131350.","journal-title":"Neuropharmacology"},{"key":"BF03033793_CR148","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1460-9568.1996.tb01228.x","volume":"8","author":"CG. Parsons","year":"1996","unstructured":"Parsons, CG., Panchenko, V.A., Pinchenko, V.O., Tsyndrenko, A.Y. and Krishtal, O.A. (1996) Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine.Eur. J. Neuwsci. 8, 446\u2013454.","journal-title":"Eur. J. Neuwsci."},{"key":"BF03033793_CR149","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0028-3908(95)00092-K","volume":"34","author":"CG. Parsons","year":"1995","unstructured":"Parsons, CG., Quack, G., Bresink, I., Baran, L., Przegalinski, E., Kostowski, W., Krzascik, P., Hartmann, S. and Danysz, W. (1995) Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonistsin vitro with anticonvulsive and motor impairment activityin vivo.Neuropharmacology 34, 1239\u20131258.","journal-title":"Neuropharmacology"},{"key":"BF03033793_CR150","volume-title":"The Rat Brain in Stereotaxic Coordinates","author":"G. Paxinos","year":"1997","unstructured":"Paxinos, G. and Watson, C. (1997)The Rat Brain in Stereotaxic Coordinates (San Diego, CA: Academic Press)."},{"key":"BF03033793_CR151","volume-title":"New neuroethology on the move 1998, Proceedings of the 26th G\u00f6ttingen Neurobiology Conference","author":"V. Pedersen","year":"1998","unstructured":"Pedersen, V. and Schmidt, W.J. (1998) Differential expression of immediate early genes in the basal ganglia of 6-OHDA lesioned rats. Eisner, N. and Wehner, R. (Eds.),New neuroethology on the move 1998, Proceedings of the 26th G\u00f6ttingen Neurobiology Conference, Stuttgart, Thieme, Vol. 1, No. 64."},{"key":"BF03033793_CR152","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1367-5931(99)80064-7","volume":"3","author":"R. Pellicciari","year":"1999","unstructured":"Pellicciari, R. and Costantino, G. (1999) Metabotropic G- protein-coupled glutamate receptors as therapeutic targets.Curr. Opin. Chem. Biol. 3, 433\u2013440.","journal-title":"Curr. Opin. Chem. Biol."},{"key":"BF03033793_CR153","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/neur.1995.0044","volume":"4","author":"S. Perovic","year":"1995","unstructured":"Perovic, S., Pergande, G., Ushijima, H., Kelve, M., Forrest, J. and M\u00fcller, W.E.G. (1995) Flupirtine partially prevents neuronal injury induced by prion protein fragment and lead acetate.Neurodegeneration 4, 369\u2013374.","journal-title":"Neurodegeneration"},{"key":"BF03033793_CR154","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-2999(96)00712-1","volume":"317","author":"S. Perovic","year":"1996","unstructured":"Perovic, S., Pialoglou, P., Schr\u00f6der, H.C., Pergande, G. and M\u00fcller, W.E.G. (1996) Flupirtine increases the levels of glutathione and Bcl-2 in hNT (human Ntera\/D1) neurons: mode of action of the drug-mediated anti-apoptotic effect.Eur. ]. Pharmacol. 317, 157\u2013164.","journal-title":"Eur. ]. Pharmacol."},{"key":"BF03033793_CR155","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1006\/exnr.1997.6559","volume":"147","author":"S. Perovic","year":"1997","unstructured":"Perovic, S., Schr\u00f6der, H.C, Pergande, G., Ushijima, H. and M\u00fcller, W.E.G. (1997) Effect of flupirtine on Bcl-2 and glutathione level in neuronal cells treatedin vitro with the prion protein fragment (PrPl06-126).Exp. Neurol. 147, 518\u2013524.","journal-title":"Exp. Neurol."},{"key":"BF03033793_CR156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0028-3908(94)00129-G","volume":"34","author":"J.P. Pin","year":"1995","unstructured":"Pin, J.P. and Duvoisin, R. (1995) The metabotropic glutamate receptors: structure and functions.Neuropharmacology 34, 1\u201326.","journal-title":"Neuropharmacology"},{"key":"BF03033793_CR157","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1523\/JNEUROSCI.15-05-03775.1995","volume":"15","author":"C Portera-Cailliau","year":"1995","unstructured":"Portera-Cailliau, C, Hedreen, J.C, Price, D.L. and Koliatsos, V.E. (1995) Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models.J. Neurosci. 15, 3775\u20133787.","journal-title":"J. Neurosci."},{"key":"BF03033793_CR158","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0166-2236(92)90034-6","volume":"15","author":"H.A. Robertson","year":"1992","unstructured":"Robertson, H.A. (1992) Dopamine interactions: some implications for the treatment of Parkinson\u2019s disease.Trends Neurosci. 15, 201\u2013205.","journal-title":"Trends Neurosci."},{"key":"BF03033793_CR159","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0166-2236(87)90177-9","volume":"10","author":"S.M. Rothman","year":"1987","unstructured":"Rothman, S.M. and Olney, J.W. (1987) Excitotoxicity and the NMDA receptor.Trends Neurosci. 10, 299\u2013302.","journal-title":"Trends Neurosci."},{"key":"BF03033793_CR160","first-page":"7","volume":"68","author":"J.D. Rothstein","year":"1995","unstructured":"Rothstein, J.D. (1995) Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis.Adv.Neurol. 68, 7\u201320.","journal-title":"Adv.Neurol."},{"key":"BF03033793_CR161","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0014-2999(95)00570-6","volume":"294","author":"K. Rupalla","year":"1995","unstructured":"Rupalla, K., Cao, W. and Krieglstein, J. (1995) Flupirtine protects neurons against excitotoxic or ischemic damage and inhibits the increase in cytosolic Ca2+ concentration.Eur. J. Pharmacol. 294, 469\u2013473.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033793_CR162","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0006-8993(92)91628-R","volume":"586","author":"M. Santiago","year":"1992","unstructured":"Santiago, M., Venero, J.L., Machado, A. and Cano, J. (1992)In vivo protection of striatum from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists.Brain Res. 586, 203\u2013207.","journal-title":"Brain Res."},{"key":"BF03033793_CR163","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1471-4159.1999.0720129.x","volume":"72","author":"M.D. S\u00e1nchez-Carbente","year":"1999","unstructured":"S\u00e1nchez-Carbente, M.D. and Massieu, L. (1999) Transient inhibition of glutamate uptakein vivo induces neuro degeneration when energy metabolism is impaired.J. Neurochem. 72, 129\u2013138.","journal-title":"J. Neurochem."},{"key":"BF03033793_CR164","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mds.870050406","volume":"5","author":"A.H. Schapira","year":"1990","unstructured":"Schapira, A.H., Holt, I.J., Sweeney, M., Harding, A.E., Jenner, P. and Marsden, CD. (1990) Mitochondrial DNA analysis in Parkinson\u2019s disease.Mov. Disord. 5, 294\u2013297.","journal-title":"Mov. Disord."},{"key":"BF03033793_CR165","first-page":"63","volume":"43","author":"W.J. Schmidt","year":"1994","unstructured":"Schmidt, W.J. (1994) Behavioural effects of NMDA-receptor antagonists.J. Neural Transm. 43 (Suppl.), 63\u201369.","journal-title":"J. Neural Transm."},{"key":"BF03033793_CR166","first-page":"67","volume":"46","author":"W.J. Schmidt","year":"1995","unstructured":"Schmidt, W.J. (1995) Balance of transmitter activities in the basal ganglia loops.J. Neural Transm. 46, 67\u201376.","journal-title":"J. Neural Transm."},{"key":"BF03033793_CR167","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0091-3057(89)90007-5","volume":"32","author":"W.J. Schmidt","year":"1989","unstructured":"Schmidt, W.J. and Bubser, M. (1989) Anticataleptic effects of N-methyl-D-aspartate antagonist MK-801 in rats.Pharmacol. Biochem. Behav. 32, 621\u2013623.","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BF03033793_CR168","first-page":"65","volume":"38","author":"W.J. Schmidt","year":"1992","unstructured":"Schmidt, W.J., Bubser, M. and Hauber, W. (1992) Behavioral pharmacology of glutamate in the basal ganglia.J. Neural Transm. 38, 65\u201389.","journal-title":"J. Neural Transm."},{"key":"BF03033793_CR169","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0149-7634(96)00044-9","volume":"21","author":"W.J. Schmidt","year":"1997","unstructured":"Schmidt, W.J. and Kretschmer, B.D. (1997) Behavioral pharmacology of glutamate receptors in the basal ganglia.Neurosci. Biobehav. Rev. 21, 381\u2013392.","journal-title":"Neurosci. Biobehav. Rev."},{"key":"BF03033793_CR170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(97)89671-9","volume":"327","author":"W.J. Schmidt","year":"1997","unstructured":"Schmidt, W.J., Schuster, G., Wacker, E. and Pergande, G. (1997) Antiparkinsonian and other motor effects of flupirtine alone and in combination with dopaminergic drugs.Eur. J. Pharmacol. 327, 1\u20139.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033793_CR171","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00806920","volume":"1","author":"W.J. Schmidt","year":"1991","unstructured":"Schmidt, W.J., Zadow, B., Kretschmer, B.D. and Hauber, W. (1991) Anticataleptic potencies of glutamate-antagonists.Amin. Acids 1, 225\u2013237.","journal-title":"Amin. Acids"},{"key":"BF03033793_CR172","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0014-2999(90)90539-I","volume":"176","author":"H. Schoemaker","year":"1990","unstructured":"Schoemaker, H., Allen, J. and Langer, S.Z. (1990) Binding of [3H]ifenprodil, a novel NMDA antagonist, to a polyamine- sensitive site in the rat cerebral cortex.Eur. J. Pharmacol. 176, 249\u2013250.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03033793_CR173","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0165-6147(93)90107-U","volume":"14","author":"D.D. Schoepp","year":"1993","unstructured":"Schoepp, D.D. and Conn, P.J. (1993) Metabotropic glutamate receptors in brain function and pathology.Trends Pharmacol. Sci. 14, 13\u201320.","journal-title":"Trends Pharmacol. Sci."},{"key":"BF03033793_CR174","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1527-3458.1998.tb00061.x","volume":"4","author":"G. Schuster","year":"1998","unstructured":"Schuster, G., Schwarz, M., Block, F., Pergande, G. and Schmidt, W.J. (1998) Flupirtine:areviewofitsneuroprotective and behavioral properties.CNS Drug Rev. 4, 149\u2013164.","journal-title":"CNS Drug Rev."},{"key":"BF03033793_CR175","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1097\/00001756-199410000-00036","volume":"5","author":"M. Schwarz","year":"1994","unstructured":"Schwarz, M., Block, F. and Pergande, G. (1994) N-methyl-D- aspartate (NMDA)-mediated muscle relaxant action of flupirtine in rats.Neuroreport 5, 1981\u20131984.","journal-title":"Neuroreport"},{"key":"BF03033793_CR176","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF01273155","volume":"103","author":"M. Schwarz","year":"1996","unstructured":"Schwarz, M., Nolden-Koch, M., Purr, J., Pergande, G. and Block, F. (1996) Antiparkinsonian effect of flupirtine in monoamine-depleted rats.J. Neural Transm. 103, 581\u2013590.","journal-title":"J. Neural Transm."},{"key":"BF03033793_CR177","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/0306-4522(94)90345-X","volume":"62","author":"F.R. Sharp","year":"1994","unstructured":"Sharp, F.R., Butman, M., Koistinaho, J., Aardalen, K., Nakki, R., Massa, S.M., Swanson, R.A. and Sagar, S.M. (1994) Phencyclidine induction of thehsp 70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels.Neuroscience 62, 1079\u20131092.","journal-title":"Neuroscience"},{"key":"BF03033793_CR178","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0022-510X(94)90170-8","volume":"124","author":"P.J. Shaw","year":"1994","unstructured":"Shaw, P.J. (1994) Excitotoxicity and motor neurone disease: a review of the evidence.J. Neurol. Sci. 124 (Suppl.), 6\u201313.","journal-title":"J. Neurol. Sci."},{"key":"BF03033793_CR179","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1523\/JNEUROSCI.09-05-01579.1989","volume":"9","author":"R. Siman","year":"1989","unstructured":"Siman, R., Noszek, J.C and Kegerise, C. (1989) Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage.J. Neurosci. 9, 1579\u20131590.","journal-title":"J. Neurosci."},{"key":"BF03033793_CR180","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0306-4522(96)00326-0","volume":"75","author":"N.A. Simonian","year":"1996","unstructured":"Simonian, N.A., Getz, R.L., Leveque, J.C, Konradi, C. and Coyle, J.T. (1996) Kainic acid induces apoptosis in neurons.Neuroscience 75, 1047\u20131055.","journal-title":"Neuroscience"},{"key":"BF03033793_CR181","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/317717a0","volume":"317","author":"F. Sladeczek","year":"1985","unstructured":"Sladeczek, F., Pin, J.P., Recasens, M., Bockaert, J. and Weiss, S. (1985) Glutamate stimulates inositol phosphate formation in striatal neurones.Nature 317, 717\u2013719.","journal-title":"Nature"},{"key":"BF03033793_CR182","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/j.1471-4159.1992.tb10081.x","volume":"58","author":"P.K. Sonsalla","year":"1992","unstructured":"Sonsalla, P.K., Zeevalk, G.D., Manzino, L., Giovanni, A. and Nicklas, W.J. (1992) MK-801 fails to protect against the dopaminergic neuropathology produced by systemic l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats.J. Neurochem. 58, 1979\u20131982.","journal-title":"J. Neurochem."}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033793.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03033793\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T05:31:00Z","timestamp":1739251860000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03033793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":182,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["BF03033793"],"URL":"https:\/\/doi.org\/10.1007\/bf03033793","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"type":"print","value":"1029-8428"},{"type":"electronic","value":"1476-3524"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}